Imminent Death Donation: Beyond Ethical Analysis and into Practice

J. Potter , “Imminent Death Donation: Ethical And Practical Policy Considerations,” Journal of Law, Medicine & Ethics 46, no. 2 (2018): 524-537.

P.E. Morrissey , “The Case for Kidney Donation Before End-of-Life Care,” American Journal of Bioethics 12, no. 6 (2012):1-8; P.E. Morrissey, “Organ Donation and Imminent Death: Pro Position,” Current Opinion in Organ Transplantation 22, no. 2 (2017):179-183; G. S. Lee, V. S. Potluri, and P.P. Reese, “The Case Against Imminent Death Donation,” Current Opinion in Organ Transplantation 22, no. 2 (2017): 184-188.

L. Bolton , “Ethical Considerations of Imminent Death Donation OPTN/UNOS Ethics Committee,” 2016, available at <https://optn.transplant.hrsa.gov/governance/public-comment/ethical-considerations-of-imminent-death-donation> (last visited May 23, 2018).

L. Bolton “Living Organ Donation by Persons with Certain Fatal Diseases Who Meet the Criteria to Be Living Organ Donors,” 2017, available at <https://optn.transplant.hrsa.gov/governance/public-comment/living-donation-by-persons-with-certain-fatal-diseases/> (last visited May 23, 2018).

M.M. Abecassis , R. Burke , and G.B. Klintmalm , et al., “American Society of Transplant Surgeons Transplant Center Outcomes Requirements — A Threat to Innovation,” American Journal of Transplantation 9, no. 6 (2009):1279-1286; J. D. Schold, L.D. Buccini, and T. R. Srinivas, et al., “The Association of Center Performance Evaluations and Kidney Transplant Volume in the United States,” American Journal of Transplantation 13, no. 1 (2013): 67-75; C. Jay and J. D. Schold, “Measuring Transplant Center Performance: The Goals are Not Controversial but the Methods and Consequences Can Be,” Current Transplantation Reports 4, no. 1 (2017): 52-58; P. P. Reese, M.N. Harhay, P. L. Abt, M. H. Levine, and S. D. Halpern, “New Solutions to Reduce Discard of Kidneys Donated for Transplantation,” Journal of the American Society of Nephrology 27, no. 4 (2016):973-980.

OPTN Policies, 2018, available at <https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf, pg 228; pg 197> (last visited April 14 2018).

P.P. Reese , N. Boudville , and A.X. Garg , “Living Kidney Donation: Outcomes, Ethics, and Uncertainty,” Lancet 385, no. 9981 (2015): 2003-2013; K.L. Lentine, B. L. Kasiske, and A.S. Levey, et al., “KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors,” Transplantation 101, no. 8S (2017): S1-S109.

OPTN Policies, supra note 6; C. Thiessen , E. J. Gordon , P. P. Reese , and S. Kulkarni , “Development of a Donor-Centered Approach to Risk Assessment: Rebalancing Nonmaleficence and Autonomy,” American Journal of Transplantation 15, no. 9 (2015): 2314-2323.

UNOS Strategic Goals, 2018, available at <https://unos.org/about/strategic-goals/> (Last visited April 10, 2018).

R. A. Denu , E. A. Mendonca , and N. Fost , “Potential Yield of Imminent Death Kidney Donation,” American Journal of Transplantation 18, no. 2 (2018): 486-491.

R. M. Veatch , Death, Dying, and the Biological Revolution (New Haven, Connecticut: Yale University Press, 1976): 72-76; R. M. Veatch and L. F. Ross. Defining Death: The Case for Choice: Transplantation Ethics (Washington, D. C.: Georgetown University Press, 2015).